P
PharmChem Inc
OTC:PCHM
PharmChem Inc
OTC:PCHM
Price:
3.75
USD
0.27%
Market Closed
Market Cap:
$17.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PharmChem Inc
OTC:PCHM
|
US |
|
Nakanishi Inc
TSE:7716
|
JP |
|
L
|
Lithium Lion Metals Inc
CNSX:LLM
|
CA |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
HK |
Income Statement
Earnings Waterfall
PharmChem Inc
PharmChem Inc
Income Statement
PharmChem Inc
PharmChem Inc
Currency: USD
| Sep-1995 | Dec-1995 | Mar-1996 | Jun-1996 | Sep-1996 | Dec-1996 | Mar-1997 | Jun-1997 | Sep-1997 | Dec-1997 | Mar-1998 | Jun-1998 | Sep-1998 | Dec-1998 | Mar-1999 | Jun-1999 | Sep-1999 | Dec-1999 | Mar-2000 | Jun-2000 | Sep-2000 | Dec-2000 | Mar-2001 | Jun-2001 | Sep-2001 | Dec-2001 | Mar-2002 | Jun-2002 | Sep-2002 | Dec-2002 | Mar-2003 | Jun-2003 | Sep-2003 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
38
N/A
|
39
+4%
|
40
+3%
|
41
+3%
|
42
+1%
|
41
-1%
|
40
-2%
|
40
-2%
|
39
-1%
|
39
+0%
|
40
+1%
|
41
+4%
|
42
+3%
|
43
+2%
|
44
+1%
|
44
-1%
|
44
+1%
|
44
+1%
|
45
+1%
|
45
+1%
|
45
+0%
|
39
-13%
|
46
+16%
|
43
-6%
|
41
-5%
|
37
-11%
|
34
-6%
|
33
-3%
|
31
-7%
|
30
-3%
|
29
-4%
|
28
-3%
|
28
-1%
|
2
-95%
|
3
+103%
|
5
+51%
|
6
+30%
|
6
0%
|
6
0%
|
6
+0%
|
6
+2%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(28)
|
(30)
|
(31)
|
(32)
|
(32)
|
(32)
|
(31)
|
(31)
|
(31)
|
(31)
|
(31)
|
(32)
|
(31)
|
(32)
|
(32)
|
(31)
|
(31)
|
(31)
|
(31)
|
(32)
|
(32)
|
(29)
|
(33)
|
(35)
|
(35)
|
(33)
|
(30)
|
(28)
|
(24)
|
(23)
|
(22)
|
(22)
|
(21)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Gross Profit |
9
N/A
|
9
0%
|
9
0%
|
9
+1%
|
10
+2%
|
10
0%
|
9
-4%
|
9
-6%
|
8
-11%
|
8
+4%
|
8
+4%
|
10
+15%
|
11
+16%
|
12
+5%
|
12
+6%
|
12
+0%
|
13
+5%
|
13
+2%
|
14
+3%
|
14
+2%
|
14
-2%
|
10
-23%
|
12
+19%
|
9
-30%
|
6
-30%
|
4
-34%
|
4
-3%
|
6
+51%
|
7
+11%
|
7
+8%
|
6
-8%
|
6
-4%
|
6
+2%
|
1
-85%
|
2
+102%
|
3
+53%
|
4
+30%
|
4
-2%
|
4
+0%
|
4
0%
|
4
+1%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(8)
|
(9)
|
(18)
|
(18)
|
(18)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(12)
|
(13)
|
(13)
|
(12)
|
(11)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
| Selling, General & Administrative |
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(10)
|
(11)
|
(13)
|
(13)
|
(12)
|
(11)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
(1)
|
(9)
|
(9)
|
(9)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
1
N/A
|
1
-65%
|
(9)
N/A
|
(9)
-2%
|
(9)
-2%
|
0
N/A
|
0
-36%
|
(0)
N/A
|
(1)
-631%
|
(1)
+11%
|
(1)
+28%
|
(0)
+89%
|
1
N/A
|
1
+20%
|
2
+42%
|
2
+14%
|
3
+33%
|
3
+6%
|
3
+3%
|
3
N/A
|
2
-18%
|
1
-65%
|
1
+17%
|
(4)
N/A
|
(7)
-58%
|
(8)
-19%
|
(7)
+9%
|
(3)
+61%
|
(2)
+41%
|
(1)
+54%
|
(1)
-49%
|
(1)
-25%
|
(1)
+24%
|
0
N/A
|
0
+135%
|
1
+82%
|
1
+44%
|
1
-5%
|
1
+48%
|
1
+9%
|
2
+11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
(9)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
1
N/A
|
(9)
N/A
|
(9)
-4%
|
(9)
-2%
|
(9)
-2%
|
0
N/A
|
(0)
N/A
|
(1)
-233%
|
(1)
-164%
|
(1)
+6%
|
(1)
+17%
|
(0)
+55%
|
1
N/A
|
1
+44%
|
1
+62%
|
2
+19%
|
2
+36%
|
3
+4%
|
3
+2%
|
3
+1%
|
2
-19%
|
1
-73%
|
1
+25%
|
(6)
N/A
|
(8)
-45%
|
(10)
-17%
|
(9)
+6%
|
(3)
+62%
|
(2)
+33%
|
(1)
+40%
|
(2)
-25%
|
(2)
-21%
|
(1)
+52%
|
0
N/A
|
0
+127%
|
1
+79%
|
1
+43%
|
1
-5%
|
1
+45%
|
2
+9%
|
2
+10%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(0)
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
1
|
(7)
|
(7)
|
(7)
|
(7)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
1
|
2
|
2
|
3
|
2
|
3
|
2
|
0
|
0
|
(6)
|
(8)
|
(9)
|
(9)
|
(3)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Net Income (Common) |
1
N/A
|
(7)
N/A
|
(7)
-4%
|
(7)
-1%
|
(7)
0%
|
0
N/A
|
(0)
N/A
|
(1)
-233%
|
(1)
-164%
|
(1)
+4%
|
(1)
+15%
|
(1)
+48%
|
0
N/A
|
1
+44%
|
1
+122%
|
2
+8%
|
2
+28%
|
3
+44%
|
2
-11%
|
3
+0%
|
2
-15%
|
1
-36%
|
0
-73%
|
(6)
N/A
|
(8)
-37%
|
(8)
-11%
|
(3)
+59%
|
2
N/A
|
3
+44%
|
3
+22%
|
(2)
N/A
|
(2)
-20%
|
(1)
+52%
|
0
N/A
|
0
+131%
|
1
+71%
|
1
+58%
|
1
-12%
|
1
+53%
|
1
+11%
|
1
+9%
|
|
| EPS (Diluted) |
0.13
N/A
|
-1.22
N/A
|
-1.27
-4%
|
-1.24
+2%
|
-1.25
-1%
|
0.01
N/A
|
-0.03
N/A
|
-0.09
-200%
|
-0.24
-167%
|
-0.22
+8%
|
-0.19
+14%
|
-0.1
+47%
|
0.08
N/A
|
0.1
+25%
|
0.24
+140%
|
0.26
+8%
|
0.33
+27%
|
0.47
+42%
|
0.42
-11%
|
0.42
N/A
|
0.36
-14%
|
0.22
-39%
|
0.06
-73%
|
-0.95
N/A
|
-1.3
-37%
|
-1.44
-11%
|
-0.58
+60%
|
0.32
N/A
|
0.46
+44%
|
0.57
+24%
|
-0.3
N/A
|
-0.35
-17%
|
-0.17
+51%
|
0.03
N/A
|
0.06
+100%
|
0.11
+83%
|
0.17
+55%
|
0.15
-12%
|
0.24
+60%
|
0.27
+13%
|
0.3
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
